PATENT CLAIM ANALYSIS

Application Number: 16067444
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-01
Patent Classification: ["544", "326000"]

Abstract:
Disclosed in the present invention are an acrylanilide compound represented by general formula (I) and a pharmaceutically acceptable salt thereof. The acrylanilide compound and the pharmaceutically acceptable salt thereof are used for treating clinical diseases by mainly acting on EGFR family casein kinases.

Claim (Index 16):
Use of the compound or the pharmaceutically acceptable salts thereof according to  claim 1  in the preparation of medicaments for the prevention or treatment of cancers.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 94.0
- Lexical Diversity: 1.30556
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['11728897', '15745187', '12865339', '12755301', '13386645']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8378575493939623
- 35 USC 102 Novelty (BERT): 0.553649129037076
- Combined Prediction Score: 0.8094367073582737
- Mean Citation Score: 420.294502
- Max Citation Score: 433.8232
- Similarity Product: 319.0542767255306

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test